High protein supplement
US7982066B2 · kind B2 · utility
8Cited by
22References
29Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 9, 2008 |
| Grant date | Jul 19, 2011 |
| Priority date | — |
| Expiry date | Sep 16, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to high protein dietary supplements for treating various symptoms and diseases associated with protein deficiency including weight gain, obesity, catabolic diseases, fibromyalgia, anxiety reactions, posttraumatic stress and chronic fatigue syndrome. Embodiments of dietary supplements comprise combinations of proteins, essential and semi-essential amino acids including L-Lysine, L-Arginine, and/or L-Histidine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.